Form 4 Tracker
Martine A Rothblatt

Director; Director, Chairperson & CEO · 81 filings · Latest: Jun 17, 2026

BETA Technologies, Inc.
UNITED THERAPEUTICS Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 23, 2026
Sale
$572.359,500$5.4M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 23, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 22, 2026
Sale
$576.569,500$5.5M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 22, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 21, 2026
Sale
$570.429,500$5.4M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 21, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 20, 2026
Sale
$577.839,500$5.5M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 20, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 17, 2026
Sale
$586.669,500$5.6M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 17, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 16, 2026
Sale
$577.219,500$5.5M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 16, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 15, 2026
Sale
$580.369,500$5.5M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 15, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 14, 2026
Sale
$579.369,500$5.5M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 14, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 13, 2026
Sale
$536.9575$40.3K324,443
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 13, 2026
Sale
$574.869,500$5.5M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 13, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOApr 10, 2026
Sale
$569.289,500$5.4M40,513